A detailed history of Cva Family Office, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Cva Family Office, LLC holds 37 shares of ELAN stock, worth $528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Holding current value
$528
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$12.93 - $18.45 $478 - $682
37 New
37 $0
Q1 2023

Apr 26, 2023

BUY
$8.79 - $14.58 $3,515 - $5,832
400 New
400 $3,000
Q3 2022

Nov 22, 2022

BUY
$12.41 - $32.42 $2,419 - $6,321
195 New
195 $2,000
Q1 2022

Apr 22, 2022

SELL
$24.65 - $29.0 $3,574 - $4,205
-145 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$27.74 - $34.09 $4,022 - $4,943
145 New
145 $4,000
Q2 2021

Jul 13, 2021

SELL
$28.76 - $35.98 $5,752 - $7,195
-200 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$27.85 - $34.49 $5,570 - $6,898
200 New
200 $6,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.78B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.